Indian Pharma's Innovation Success in 2025

Indian pharmaceutical companies, long known for generics, saw their risky innovation bets yield major commercial success in 2025 through global deals and approvals. Discover the key players and what's next for 2026.

ICICI Prudential CIO: Avoid Gold, Silver as Solo Bets

ICICI Prudential Mutual Fund's Sankaran Naren advises caution on precious metals, recommends equity-focused asset allocation. He cites high valuations and equity supply for moderate market returns.

Karnal Pharma Park Delays Leave Drug Makers in Limbo

Pharmaceutical manufacturers in Haryana await land allocation for the Karnal Pharma Park, a project delayed since 2021. The park promises to boost drug production and exports. Read about the industry's demands and government's plans.

Steel Prices Jump After New Import Duty, Construction Hit

India's new safeguard duty on select steel imports has led to a sharp price rise of up to Rs 8,000 per tonne. Industry warns of a 2% increase in construction costs, impacting real estate and auto sectors. Read more.

Trader wins $400k betting on Maduro removal before US op

A single trader earned over $400,000 on crypto betting platform Polymarket by wagering on Nicolás Maduro's removal, just hours before a secret US mission. The timing raises insider trading concerns. Read the full investigation.

Page 10 of 477